ABBOTT LABORATORIES
Government Contracts & Awards
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
These 3 Companies Reported Record Results and Raised Guidance
Abbott Laboratories, Taiwan Semiconductor, and Johnson & Johnson have all delivered strong earnings releases in the Q2 cycle, with each breaking records while also lifting their outlooks.
Abbott Laboratories (ABT) Fell as Guidance and Litigation Concerns Overshadowed Growth
Jensen Investment Management, an asset management company based in the US, released its second-quarter 2026 investor letter for the “Jensen Quality Growth Equity Strategy”. A copy of the letter is available to download here. The fund seeks long-term growth by investing in high-quality companies with durable competitive advantages. It returned 10.94% net of fees in […]
Zacks Investment Ideas feature highlights: General Motors, Abbott Laboratories and Johnson & Johnson
GM, ABT and JNJ stand out this earnings season after raising guidance, boosting outlooks and reinforcing momentum with stronger-than-expected quarterly results.
Abbott Laboratories (ABT) Earnings Drew Fresh Attention, Is It Still Below Fair Value?
Abbott Laboratories earnings put recent stock moves in context Abbott Laboratories (ABT) is back in focus after its latest quarterly earnings, where higher year over year sales came alongside lower net income and earnings per share, sharpening attention on upcoming estimates. See our latest analysis for Abbott Laboratories. After these earnings, Abbott Laboratories' recent rally stands out, with a 7 day share price return of 12.66% and a 30 day share price return of 14.51% contrasting with a...
Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories
JNJ is pruning its portfolio while Abbott just dropped $21 billion to expand into cancer diagnostics, and the two strategies are pulling their stocks in completely opposite directions. Which move looks smarter when you dig into the actual earnings?
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Abbott Laboratories: Pick Up This Dividend King Deal Now
Abbott Laboratories' strength in Medical Devices business and the recently acquired Exact Sciences should keep driving growth. Read why ABT stock is a buy.
Abbott Laboratories (ABT) Q2 2026 Earnings Call Highlights: Strong Growth in Key Segments and ...
Abbott Laboratories (ABT) reports robust sales growth and raises full-year EPS guidance, driven by strong performance in Nutrition, Medical Devices, and Emerging Markets.
Abbott (ABT) Lifts 2026 EPS Outlook Amid Business Mix Shift Toward Devices and Diagnostics
Abbott Laboratories has reported its second-quarter 2026 results, with sales rising to US$12.59 billion from US$11.14 billion a year earlier, while net income fell to US$928 million and diluted EPS from continuing operations declined to US$0.53. Despite lower net income, Abbott delivered better-than-expected adjusted earnings, lifted its full-year 2026 adjusted EPS guidance, and highlighted strong growth in higher-margin Medical Devices and Cancer Diagnostics, signalling a continued shift in...
Abbott Laboratories shares jump as earnings beat estimates and company raises 2026 outlook
Abbott Laboratories (NYSE:ABT) shares rose nearly 11% on Thursday after the healthcare company reported second quarter 2026 results that topped Wall Street expectations and raised its full-year adjusted earnings guidance. The company posted adjusted diluted earnings per share of $1.31 for the...
Congressional Trades in $ABT
Insider Trades (Form 4)
Roman Michael F
Gonzalez Patricia Paola
Cushman Elizabeth C.
Moreland Mary K
STARKS DANIEL J
Conroy Kevin T
Stratton John G
Roman Michael F
Key People
McDew Darren W
Director
OGrady Michael
Director
Kumbier Michelle
Director
Conroy Kevin T
Director
Ahuja Nita
Director
ORVILLE JACOB A
Senior Vice President
MCCOY JOHN A
VICE PRESIDENT AND CONTROLLER
Salvadori Daniel Gesua Sive
EVP AND GROUP PRESIDENT
Scoggins Christopher J
EXECUTIVE VICE PRESIDENT
Boudreau Philip P
EVP AND CFO
Cushman Elizabeth C
EVP, GC AND SECRETARY
Alpern Robert J
Director
Roman Michael F
Director
Earnhardt Lisa D
EVP AND GROUP PRESIDENT
Shroff Eric
Senior Vice President
Wainer Andrea F
RETIRED EVP
ALLEN HUBERT L
EXECUTIVE VICE PRESIDENT, GC
Ford Robert B
CHAIRMAN AND CEO
Gonzalez Patricia Paola
Director
Boudreau Philip P
EXECUTIVE VICE PRESIDENT
Political Giving
$409,000 given to 51 candidates across 137 disclosed contributions (FEC Schedule A).
Darin McKay LaHood
Bradley S. Schneider
Scott H. Peters
Adrian Smith
Terri A. Sewell
Gus M. Bilirakis
Virginia Foxx
James D Jordan
Diana Harshbarger
Nanette Barragan
Kim Schrier
Blake Moore
Elizabeth Fletcher
Suzan K. DelBene
Earl Leroy Carter
Katherine M. Clark
Angus King
David P. Joyce
Lori Trahan
Thomas Suozzi
+ 31 more recipients not shown.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro